Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | KIT |
Variant | D816_N822delinsMIDSI |
Impact List | indel |
Protein Effect | unknown |
Gene Variant Descriptions | KIT D816_N822delinsMIDSI results in a deletion of seven amino acids in tyrosine kinase domain region 2 (exon 17) of the Kit protein from amino acids 816 to 822, combined with the insertion of five amino acids at the same site (PMID: 17555444). D816_N822delinsMIDSI has been identified in the scientific literature (PMID: 38273969), but has not been biochemically characterized and therefore, its effect on Kit protein function is unknown (PubMed, Nov 2024). |
Associated Drug Resistance | |
Category Variants Paths |
KIT mutant KIT exon17 KIT D816_N822delinsMIDSI |
Transcript | NM_000222.3 |
gDNA | chr4:g.54733154_54733174delinsATGATCGACAGCATC |
cDNA | c.2446_2466delinsATGATCGACAGCATC |
Protein | p.D816_N822delinsMIDSI |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001385290.1 | chr4:g.54733154_54733174delinsATGATCGACAGCATC | c.2446_2466delinsATGATCGACAGCATC | p.D816_N822delinsMIDSI | RefSeq | GRCh38/hg38 |
NM_000222.3 | chr4:g.54733154_54733174delinsATGATCGACAGCATC | c.2446_2466delinsATGATCGACAGCATC | p.D816_N822delinsMIDSI | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
KIT D816_N822delinsMIDSI | systemic mastocytosis | predicted - sensitive | Avapritinib | Case Reports/Case Series | Actionable | In a clinical case study, Ayvakit (avapritinib) treatment resulted in improved symptoms, reduced tryptase levels, and reduced lymphadenopathy in a patient with systemic mastocytosis harboring KIT D816_N822delinsMIDSI (PMID: 38273969). | 38273969 |